Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal
Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal
Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal
Submitted by
admin
on October 10, 2017 - 9:50am
Source:
Endpoints
News Tags:
Merck
KalVista
KVD001
diabetic macular edema
Headline:
Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal
Do Not Allow Advertisers to Use My Personal information
